| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 189,907 | 172,367 | 175,147 | 180,895 | | Cost of Revenue |
-
| 40,339 | 44,062 | 51,126 | | | Gross Profit |
-
| 132,028 | 131,085 | 129,769 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,975 | 25,360 | 30,933 | 25,399 | | Non Recurring |
-
| 8,609 | 4,786 | 1,720 | | Others | 69,750 | 52,921 | 52,200 | 54,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 45,138 | 43,166 | 48,650 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 80,462 | 45,138 | 43,166 | 48,650 | | Interest Expense | 67,905 | 31,527 | 31,486 | 31,560 | | Income Before Tax | 12,557 | 13,611 | 11,680 | 17,090 | | Income Tax Expense | 4,646 | 4,006 | 5,647 | 6,074 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,911 | 9,605 | 6,033 | 11,016 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,911 | 9,605 | 6,033 | 11,016 | | Preferred Stock And Other Adjustments |
-
|
-
| (3,533) | (2,606) | | | Net Income Applicable To Common Shares | $7,911 | $9,605 | $2,500 | $8,410 |
|
0.35% Nasdaq 0.00%
Income Statement
